Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares US Pharmaceuticals ETF (Symbol: IHE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $116.08 per unit. With IHE trading at a recent price near $102.53 per unit, that means that analysts see 13.21% upside for this ETF looking through to the average analyst targets of the underlying holdings.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。